Value of PET imaging for radiation therapy

Constantin Lapa¹, Ursula Nestle^{2

3

4}, Nathalie L Albert⁵, Christian Baues⁶, Ambros Beer⁷, Andreas Buck⁸, Volker Budach⁹, Rebecca Bütof^{10

11}, Stephanie E Combs^{12

13

14}, Thorsten Derlin¹⁵, Matthias Eiber¹⁶, Wolfgang P Fendler¹⁷, Christian Furth¹⁸, Cihan Gani^{19

20}, Eleni Gkika², Anca L Grosu^{2

3}, Christoph Henkenberens²¹, Harun Ilhan⁵, Steffen Löck^{10

11}, Simone Marnitz-Schulze⁶, Matthias Miederer²², Michael Mix²³, Nils H Nicolay^{2

3}, Maximilian Niyazi^{5

12}, Christoph Pöttgen²⁴, Claus M Rödel^{25

26}, Imke Schatka¹⁸, Sarah M Schwarzenboeck²⁷, Andrei S Todica⁵, Wolfgang Weber¹⁶, Simone Wegen⁶, Thomas Wiegel²⁸, Constantinos Zamboglou^{2

3}, Daniel Zips^{19

20}, Klaus Zöphel^{11

29

30

31

32}, Sebastian Zschaeck³³, Daniela Thorwarth^{19

34}, Esther G C Troost^{10

11

29

30

35}; “Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN”

Affiliations

¹ Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
² Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
³ German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
⁴ Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany.
⁵ Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
⁶ Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
⁷ Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
⁸ Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
⁹ Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
¹⁰ Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
¹¹ OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
¹² German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
¹³ Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
¹⁴ Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Neuherberg, Germany.
¹⁵ Department of Nuclear Medicine, Hannover Medical School, Germany.
¹⁶ Department of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
¹⁷ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
¹⁸ Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁹ German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁰ Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
²¹ Department of Radiotherapy and Special Oncology, Medical School Hannover, Germany.
²² Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
²³ Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
²⁴ Department of Radiation Oncology, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany.
²⁵ German Cancer Consortium (DKTK), Partner Site Frankfurt, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁶ Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt, Germany.
²⁷ Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.
²⁸ Department of Radiation Oncology, Ulm University Hospital, Ulm, Germany.
²⁹ National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
³⁰ German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
³¹ Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
³² Department of Nuclear Medicine, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
³³ Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
³⁴ Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
³⁵ Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.

PMID: 34261141
DOI: 10.1055/a-1525-7029

Review

Value of PET imaging for radiation therapy

Constantin Lapa et al. Nuklearmedizin. 2021 Oct.

. 2021 Oct;60(5):326-343.

doi: 10.1055/a-1525-7029. Epub 2021 Jul 14.

Authors

Affiliations

¹ Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
² Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
³ German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
⁴ Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany.
⁵ Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
⁶ Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
⁷ Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
⁸ Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
⁹ Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
¹⁰ Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
¹¹ OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
¹² German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
¹³ Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
¹⁴ Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Neuherberg, Germany.
¹⁵ Department of Nuclear Medicine, Hannover Medical School, Germany.
¹⁶ Department of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
¹⁷ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
¹⁸ Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
¹⁹ German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁰ Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
²¹ Department of Radiotherapy and Special Oncology, Medical School Hannover, Germany.
²² Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
²³ Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
²⁴ Department of Radiation Oncology, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany.
²⁵ German Cancer Consortium (DKTK), Partner Site Frankfurt, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁶ Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt, Germany.
²⁷ Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.
²⁸ Department of Radiation Oncology, Ulm University Hospital, Ulm, Germany.
²⁹ National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
³⁰ German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
³¹ Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
³² Department of Nuclear Medicine, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
³³ Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
³⁴ Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
³⁵ Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.

PMID: 34261141
DOI: 10.1055/a-1525-7029

Abstract
in English, German

This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.

Diese umfassende Übersichtsarbeit, die von Experten auf ihrem Gebiet verfasst wurde, zeigt den aktuellen Stand hinsichtlich der Einbeziehung der Positronen-Emissions-Tomografie (PET) in die Strahlenbehandlungsplanung. Darüber hinaus werden laufende Studien zur Behandlungsindividualisierung und zur Überwachung des Tumoransprechens pro Behandlung bei verschiedenen Primärtumoren vorgestellt. Neuartige Tracer und Bildanalyseverfahren werden diskutiert. Die Autoren sind der Meinung, dass dieser Beitrag sowohl für Experten auf diesem Gebiet als auch für politische Entscheidungsträger, die über die Kostenerstattung dieser leistungsstarken Bildgebungsmodalität bestimmen, von entscheidendem Wert ist.

PubMed Disclaimer

Conflict of interest statement

Wolfgang P. Fendler is a consultant for BTG, and he received fees from RadioMedix, Bayer, and Parexel outside of the submitted work.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Value of PET imaging for radiation therapy

Affiliations

Value of PET imaging for radiation therapy

Authors

Affiliations

Abstract
in English, German

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract in English, German

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract
in English, German